1932

Abstract

Men and women exhibit significant differences in obesity, cardiovascular disease, and diabetes. To provide better diagnosis and treatment for both sexes, it is important to identify factors that underlie the observed sex differences. Traditionally, sex differences have been attributed to the differential effects of male and female gonadal secretions (commonly referred to as sex hormones), which substantially influence many aspects of metabolism and related diseases. Less appreciated as a contributor to sex differences are the fundamental genetic differences between males and females, which are ultimately determined by the presence of an XX or XY sex chromosome complement. Here, we review the mechanisms by which gonadal hormones and sex chromosome complement each contribute to lipid metabolism and associated diseases, and the current approaches that are used to study them. We focus particularly on genetic approaches including genome-wide association studies in humans and mice, -omics and systems genetics approaches, and unique experimental mouse models that allow distinction between gonadal and sex chromosome effects.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-nutr-071816-064827
2017-08-21
2024-07-13
Loading full text...

Full text loading...

/deliver/fulltext/nutr/37/1/annurev-nutr-071816-064827.html?itemId=/content/journals/10.1146/annurev-nutr-071816-064827&mimeType=html&fmt=ahah

Literature Cited

  1. Ahmed-Sorour H, Bailey CJ. 1.  1981. Role of ovarian hormones in the long-term control of glucose homeostasis, glycogen formation and gluconeogenesis. Ann. Nutr. Metab. 25:208–12 [Google Scholar]
  2. Angulo P. 2.  2002. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346:1221–31 [Google Scholar]
  3. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. 3.  2011. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96:3007–19 [Google Scholar]
  4. Arnold AP. 4.  2009. Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J. Neuroendocrinol. 21:377–86 [Google Scholar]
  5. Arnold AP, Burgoyne PS. 5.  2004. Are XX and XY brain cells intrinsically different?. Trends Endocrinol. Metab. 15:6–11 [Google Scholar]
  6. Arnold AP, Chen X. 6.  2009. What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues?. Front. Neuroendocrinol. 30:1–9 [Google Scholar]
  7. Arnold AP, Chen X, Link JC, Itoh Y, Reue K. 7.  2013. Cell-autonomous sex determination outside of the gonad. Dev. Dyn. 242:371–79 [Google Scholar]
  8. Arnold AP, Reue K, Eghbali M, Vilain E, Chen X. 8.  et al. 2016. The importance of having two X chromosomes. Philos. Trans. R. Soc. B 371:20150113 [Google Scholar]
  9. Bartlett J, Predazzi IM, Williams SM, Bush WS, Kim Y. 9.  et al. 2016. Is isolated low high-density lipoprotein cholesterol a cardiovascular disease risk factor? New insights from the Framingham offspring study. Circ. Cardiovasc. Qual. Outcomes 9:206–12 [Google Scholar]
  10. Becker JB, Prendergast BJ, Liang JW. 10.  2016. Female rats are not more variable than male rats: a meta-analysis of neuroscience studies. Biol. Sex Differ. 7:34 [Google Scholar]
  11. Bittner V. 11.  2005. Perspectives on dyslipidemia and coronary heart disease in women. J. Am. Coll. Cardiol. 46:1628–35 [Google Scholar]
  12. Blouin K, Boivin A, Tchernof A. 12.  2008. Androgens and body fat distribution. J. Steroid Biochem. Mol. Biol. 108:272–80 [Google Scholar]
  13. Bojesen A, Høst C, Gravholt CH. 13.  2010. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition. Mol. Hum. Reprod. 16:396–401 [Google Scholar]
  14. Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L. 14.  et al. 2006. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29:1591–98 [Google Scholar]
  15. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD. 15.  et al. 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–95 [Google Scholar]
  16. Bukowski R, Smith GCS, Malone FD, Ball RH, Nyberg DA. 16.  et al. 2007. Human sexual size dimorphism in early pregnancy. Am. J. Epidemiol. 165:1216–18 [Google Scholar]
  17. Burgoyne PS. 17.  1993. A Y-chromosomal effect on blastocyst cell number in mice. Development 117:341–45 [Google Scholar]
  18. Burgoyne PS, Thornhill AR, Boudrean SK, Darling SM, Bishop CE, Evans EP. 18.  1995. The genetic basis of XX-XY differences present before gonadal sex differentiation in the mouse. Philos. Trans. R. Soc. B. 350:253–61 [Google Scholar]
  19. Calcaterra V, Brambilla P, Maffè GC, Klersy C, Albertini R. 19.  et al. 2014. Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics. Metab. Syndr. Relat. Disord. 12:159–64 [Google Scholar]
  20. Castelli WP, Anderson K, Wilson PW, Levy D. 20.  1992. Lipids and risk of coronary heart disease. The Framingham Study. Ann. Epidemiol. 2:23–28 [Google Scholar]
  21. Chen X, McClusky R, Chen J, Beaven SW, Tontonoz P. 21.  et al. 2012. The number of X chromosomes causes sex differences in adiposity in mice. PLOS Genet 8:e1002709 [Google Scholar]
  22. Chen X, Wang L, Loh DH, Colwell CS, Taché Y. 22.  et al. 2015. Sex differences in diurnal rhythms of food intake in mice caused by gonadal hormones and complement of sex chromosomes. Horm. Behav. 75:55–63 [Google Scholar]
  23. Chen X, Williams-Burris SM, McClusky R, Ngun TC, Ghahramani N. 23.  et al. 2013. The sex chromosome trisomy mouse model of XXY and XYY: metabolism and motor performance. Biol. Sex Differ. 4:15 [Google Scholar]
  24. Cífková R, Krajčoviechová A. 24.  2015. Dyslipidemia and cardiovascular disease in women. Curr. Cardiol. Rep. 17:609 [Google Scholar]
  25. Clark JM, Brancati FL, Diehl AM. 25.  2003. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98:960–67 [Google Scholar]
  26. Clayton JA, Collins FS. 26.  2014. Policy: NIH to balance sex in cell and animal studies. Nature 509:282–83 [Google Scholar]
  27. Clemente JC, Ursell LK, Parfrey LW, Knight R. 27.  2012. The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–70 [Google Scholar]
  28. Cohen JC, Horton JD, Hobbs HH. 28.  2011. Human fatty liver disease: old questions and new insights. Science 332:1519–23 [Google Scholar]
  29. Collins P. 29.  2008. HDL-C in post-menopausal women: an important therapeutic target. Int. J. Cardiol. 124:275–82 [Google Scholar]
  30. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW. 30.  et al. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292–95 [Google Scholar]
  31. Czyżyk A, Męczekalski B. 31.  2012. Cardiovascular and metabolic problems in Turner's syndrome patients. Arch. Perinat. Med. 18:47–52 [Google Scholar]
  32. Danska JS. 32.  2014. Sex matters for mechanism. Sci. Transl. Med. 6:258fs40 [Google Scholar]
  33. Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR. 33.  2014. XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. PNAS 111:2806–11 [Google Scholar]
  34. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P. 34.  et al. 2008. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am. J. Gastroenterol. 103:2263–71 [Google Scholar]
  35. Eyre H, Kahn R, Robertson RM. 35. , Am. Cancer Soc., Am. Diabetes Assoc., Am. Heart Assoc. Collab. Writ. Comm. 2004. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Diabetes Care 27:1812–24 [Google Scholar]
  36. Fan WQ, Yanase T, Nomura M, Okabe T, Goto K. 36.  et al. 2005. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54:1000–8 [Google Scholar]
  37. Fox CS, Liu Y, White CC, Feitosa M, Smith A V. 37.  et al. 2012. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLOS Genet 8:e1002695 [Google Scholar]
  38. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P. 38.  et al. 2007. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48 [Google Scholar]
  39. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA. 39.  et al. 2004. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin. Chem. 50:1189–200 [Google Scholar]
  40. Fried SK, Lee MJ, Karastergiou K. 40.  2015. Shaping fat distribution: new insights into the molecular determinants of depot- and sex-dependent adipose biology. Obesity 23:1345–52 [Google Scholar]
  41. Garaulet M, Pérez-Llamas F, Baraza JC, Garcia-Prieto MD, Fardy PS. 41.  et al. 2002. Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. J. Nutr. Health Aging 6:123–26 [Google Scholar]
  42. Geer EB, Shen W. 42.  2009. Gender differences in insulin resistance, body composition, and energy balance. Gend. Med. 6:Suppl. 160–75 [Google Scholar]
  43. Goff DC, Bertoni AG, Kramer H, Bonds D, Blumenthal RS. 43.  et al. 2006. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113:647–56 [Google Scholar]
  44. Gravholt CH. 44.  2004. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur. J. Endocrinol. 151:657–87 [Google Scholar]
  45. Grove KL, Fried SK, Greenberg AS, Xiao XQ, Clegg DJ. 45.  2010. A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int. J. Obes. 34:989–1000 [Google Scholar]
  46. Consort GTEx. 46.  2015. Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348:648–60 [Google Scholar]
  47. Gurka MJ, Lilly CL, Oliver MN, DeBoer MD. 47.  2014. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Metabolism 63:218–25 [Google Scholar]
  48. Hagen CP, Main KM, Kjaergaard S, Juul A. 48.  2010. FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty. Hum. Reprod. 25:3134–41 [Google Scholar]
  49. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. 49.  1997. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980–1985 World Health Organization diagnostic criteria. Diabetes Care 20:1859–62 [Google Scholar]
  50. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L. 50.  et al. 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42:949–60 [Google Scholar]
  51. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. 51.  2000. Increased adipose tissue in male and female estrogen receptor-α knockout mice. PNAS 97:12729–34 [Google Scholar]
  52. Herrera BM, Lindgren CM. 52.  2010. The genetics of obesity. Curr. Diabetes Rep. 10:498–505 [Google Scholar]
  53. Høst C, Skakkebæk A, Groth KA, Bojesen A. 53.  2014. The role of hypogonadism in Klinefelter syndrome. Asian J. Androl. 16:185–91 [Google Scholar]
  54. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V. 54.  et al. 2005. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin. Endocrinol. 63:280–93 [Google Scholar]
  55. Itoh Y, Arnold AP. 55.  2015. Are females more variable than males in gene expression? Meta-analysis of microarray datasets. Biol. Sex Differ. 6:18 [Google Scholar]
  56. Itoh Y, Mackie R, Kampf K, Domadia S, Brown JD. 56.  et al. 2015. Four core genotypes mouse model: localization of the Sry transgene and bioassay for testicular hormone levels. BMC Res. Notes 8:69 [Google Scholar]
  57. Jeffery E, Wing A, Holtrup B, Sebo Z, Kaplan JL. 57.  et al. 2016. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab 24:142–50 [Google Scholar]
  58. Johnson JL, Slentz CA, Duscha BD, Samsa GP, McCartney JS. 58.  et al. 2004. Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis 176:371–77 [Google Scholar]
  59. Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS. 59.  2010. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 59:89–97 [Google Scholar]
  60. Karastergiou K, Fried SK. 60.  2012. Sex differences in human adipose tissues: the biology of pear shape. Biol. Sex Differ. 3:13 [Google Scholar]
  61. Krebs CJ, Zhang D, Yin L, Robins DM. 61.  2014. The KRAB zinc finger protein RSL1 modulates sex-biased gene expression in liver and adipose tissue to maintain metabolic homeostasis. Mol. Cell. Biol. 34:221–32 [Google Scholar]
  62. Kuk JL, Ardern CI. 62.  2010. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care 33:2457–61 [Google Scholar]
  63. Kuk JL, Ross R. 63.  2009. Influence of sex on total and regional fat loss in overweight and obese men and women. Int. J. Obes. 33:629–34 [Google Scholar]
  64. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L. 64.  1988. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am. J. Clin. Nutr. 48:1351–61 [Google Scholar]
  65. Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R. 65.  et al. 1998. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and p450 enzymes: selective catalysis by FMO3. Biochem. Pharmacol. 56:1005–12 [Google Scholar]
  66. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després JP. 66.  1993. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 58:463–67 [Google Scholar]
  67. Li J, Chen X, McClusky R, Ruiz-Sundstrom M, Itoh Y. 67.  et al. 2014. The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: One X is better than two. Cardiovasc. Res. 102:375–84 [Google Scholar]
  68. Lima R, Wofford M, Reckelhoff JF. 68.  2012. Hypertension in postmenopausal women. Curr. Hypertens. Rep. 14:254–60 [Google Scholar]
  69. Link JC, Chen X, Arnold AP, Reue K. 69.  2013. Metabolic impact of sex chromosomes. Adipocyte 2:74–79 [Google Scholar]
  70. Link JC, Chen X, Prien C, Borja MS, Hammerson B. 70.  et al. 2015. Increased high-density lipoprotein cholesterol levels in mice with XX versus XY sex chromosomes. Arterioscler. Thromb. Vasc. Biol. 35:1778–86 [Google Scholar]
  71. Liu J, Fox CS, Hickson DA, May WD, Hairston KG. 71.  et al. 2010. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J. Clin. Endocrinol. Metab. 95:5419–26 [Google Scholar]
  72. Lozupone C, Stombaugh J, Gordon J, Jansson JK, Knight R. 72.  2012. Diversity, stability and resilience of the human gut microbiota. Nature 489:220–30 [Google Scholar]
  73. Lusis AJ, Attie AD, Reue K. 73.  2008. Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet. 9:819–30 [Google Scholar]
  74. Maas AHEM, Appelman YEA. 74.  2010. Gender differences in coronary heart disease. Neth. Heart J. 18:598–602 [Google Scholar]
  75. Magkos F, Mohammed BS, Mittendorfer B. 75.  2008. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women. Int. J. Obes. 32:1655–64 [Google Scholar]
  76. Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM. 76.  et al. 2013. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:1084–88 [Google Scholar]
  77. Mauvais-Jarvis F. 77.  2015. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol. Sex Differ. 6:14 [Google Scholar]
  78. Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A. 78.  et al. 2010. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ. Cardiovasc. Qual. Outcomes 3:135–42 [Google Scholar]
  79. Miller LR, Marks C, Becker JB, Hurn PD, Chen W-J. 79.  et al. 2017. Considering sex as a biological variable in preclinical research. FASEB J 31:29–34 [Google Scholar]
  80. Mittendorfer B. 80.  2005. Insulin resistance: Sex matters. Curr. Opin. Clin. Nutr. Metab. Care 8:367–72 [Google Scholar]
  81. Monroe AK, Dobs AS. 81.  2013. The effect of androgens on lipids. Curr. Opin. Endocrinol. Diabetes Obes. 20:132–39 [Google Scholar]
  82. Mozumdar A, Liguori G. 82.  2011. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care 34:216–19 [Google Scholar]
  83. Murthy VH, Krumholz HM, Gross CP. 83.  2004. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291:2720–26 [Google Scholar]
  84. Musatov S, Chen W, Pfaff DW, Mobbs C V, Yang X-J. 84.  et al. 2007. Silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. PNAS 104:2501–6 [Google Scholar]
  85. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H. 85.  et al. 2002. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51:2734–41 [Google Scholar]
  86. Nuutila P, Knuuti MJ, Mäki M, Laine H, Ruotsalainen U. 86.  et al. 1995. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44:31–36 [Google Scholar]
  87. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly M. 87.  et al. 2000. Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice. Biochem. Biophys. Res. Commun. 278:640–45 [Google Scholar]
  88. Ong JP, Pitts A, Younossi ZM. 88.  2008. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J. Hepatol. 49:608–12 [Google Scholar]
  89. Org E, Mehrabian M, Parks BW, Shipkova P, Liu X. 89.  et al. 2016. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes 7:313–22 [Google Scholar]
  90. Palmer BF, Clegg DJ. 90.  2015. The sexual dimorphism of obesity. Mol. Cell. Endocrinol. 402:113–19 [Google Scholar]
  91. Pan J-J, Fallon MB. 91.  2014. Gender and racial differences in nonalcoholic fatty liver disease. World J. Hepatol. 6:274–83 [Google Scholar]
  92. Parks BW, Nam E, Org E, Kostem E, Norheim F. 92.  et al. 2013. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab 17:141–52 [Google Scholar]
  93. Parks BW, Sallam T, Mehrabian M, Psychogios N, Hui ST. 93.  et al. 2015. Genetic architecture of insulin resistance in the mouse. Cell Metab 21:334–46 [Google Scholar]
  94. Paun A, Danska JS. 94.  2016. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome. Pediatr. Diabetes 17:469–77 [Google Scholar]
  95. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS. 95.  et al. 2006. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 113:898–918 [Google Scholar]
  96. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS. 96.  2009. Abdominal subcutaneous adipose tissue: a protective fat depot?. Diabetes Care 32:1068–75 [Google Scholar]
  97. Pradhan AD. 97.  2014. Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin. Chem. 60:44–52 [Google Scholar]
  98. Rochlani Y, Pothineni NV, Mehta JL. 98.  2015. Metabolic syndrome: Does it differ between women and men?. Cardiovasc. Drugs Ther. 29:329–38 [Google Scholar]
  99. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman J-M. 99.  2011. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 97:870–75 [Google Scholar]
  100. Sandberg K, Umans JG. 100. , Georget. Consens. Conf. Work Group. 2015. Recommendations concerning the new U.S. National Institutes of Health initiative to balance the sex of cells and animals in preclinical research. FASEB J 29:1646–52 [Google Scholar]
  101. Senthong V, Wang Z, Li XS, Fan Y, Wu Y. 101.  et al. 2016. Intestinal microbiota‐generated metabolite trimethylamine‐N‐oxide and 5‐year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a COURAGE‐like patient cohort. J. Am. Heart Assoc. 5:e002816 [Google Scholar]
  102. Shi H, Seeley RJ, Clegg DJ. 102.  2009. Sexual differences in the control of energy homeostasis. Front. Neuroendocrinol. 30:396–404 [Google Scholar]
  103. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE. 103.  et al. 2015. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518:187–96 [Google Scholar]
  104. Sung YJ, Pérusse L, Sarzynski MA, Fornage M, Sidney S. 104.  et al. 2016. Genome-wide association studies suggest sex-specific loci associated with abdominal and visceral fat. Int. J. Obes. 40:662–74 [Google Scholar]
  105. Tang WHW, Hazen SL. 105.  2017. Microbiome, trimethylamine N-oxide, and cardiometabolic disease. Transl. Res. 179:108–15 [Google Scholar]
  106. Tchernof A, Després J-P. 106.  2013. Pathophysiology of human visceral obesity: an update. Physiol. Rev. 93:359–404 [Google Scholar]
  107. Tjoa S, Fennessey P. 107.  1991. The identification of trimethylamine excess in man: quantitative analysis and biochemical origins. Anal. Biochem. 197:77–82 [Google Scholar]
  108. Tran TT, Yamamoto Y, Gesta S, Kahn CR. 108.  2008. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410–20 [Google Scholar]
  109. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. 109.  2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213–23 [Google Scholar]
  110. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 110.  2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–31 [Google Scholar]
  111. Unwin N, Shaw J, Zimmet P, Alberti KGMM. 111.  2002. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet. Med. 19:708–23 [Google Scholar]
  112. Wald C, Wu C. 112.  2010. Of mice and women: the bias in animal models. Science 327:1571–72 [Google Scholar]
  113. Wang X, Magkos F, Mittendorfer B. 113.  2011. Sex differences in lipid and lipoprotein metabolism: It's not just about sex hormones. J. Clin. Endocrinol. Metab. 96:885–93 [Google Scholar]
  114. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS. 114.  et al. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57–63 [Google Scholar]
  115. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, Siscovick DS. 115.  2001. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am. J. Med. 111:261–69 [Google Scholar]
  116. Wise AL, Gyi L, Manolio TA. 116.  2013. eXclusion: toward integrating the X chromosome in genome-wide association analyses. Am. J. Hum. Genet. 92:643–47 [Google Scholar]
  117. Xu Y, Nedungadi TP, Zhu L, Sobhani N, Irani BG. 117.  et al. 2011. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab 14:453–65 [Google Scholar]
  118. Yang X, Schadt EE, Wang S, Wang H, Arnold AP. 118.  et al. 2006. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 16:995–1004 [Google Scholar]
  119. Yasmeen R, Reichert B, Deiuliis J, Yang F, Lynch A. 119.  et al. 2013. Autocrine function of aldehyde dehydrogenase 1 as a determinant of diet- and sex-specific differences in visceral adiposity. Diabetes 62:124–36 [Google Scholar]
  120. Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. 120.  2013. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 62:352–60 [Google Scholar]
  121. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y. 121.  et al. 2012. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine 91:319–27 [Google Scholar]
  122. Zamboni M, Armellini F, Milani MP, De Marchi M, Todesco T. 122.  et al. 1992. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int. J. Obes. Relat. Metab. Disord. 16:495–504 [Google Scholar]
  123. Zarrinpar A, Chaix A, Yooseph S, Panda S. 123.  2014. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab 20:1006–17 [Google Scholar]
  124. Zhang H, Liu Y, Wang L, Li Z, Zhang H. 124.  et al. 2013. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J. Lipid Res. 54:345–57 [Google Scholar]
  125. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N. 125.  et al. 2016. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165:111–24 [Google Scholar]
/content/journals/10.1146/annurev-nutr-071816-064827
Loading
/content/journals/10.1146/annurev-nutr-071816-064827
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error